In-hospital cardiac rehabilitation improves the implementation of secondary prevention in patients with coronary disease;Die stationäre rehabilitation verbessert die umsetzung der therapierichtlinien zur sekundärprävention bei patienten mit koronarer herzerkrankung

Zeitschrift fur Kardiologie

Volumn 90, Issue 9, 2001, Pages 646-654

  Baessler, A ^a   Fischer, M ^a   Hengstenberg, C ^a   Holmer, S ^a   Hubauer, U ^a   Huf, V ^a   Mell, S ^a   Klein, G ^b   Riegger, G ^a   Schunkert, H ^a  

^a UNIVERSITY HOSPITAL REGENSBURG   (Germany)

^b Klinik Höhenried für Herz und Kreislaufkrankheiten Bernried   (Germany)

Author keywords

Cardiac rehabilitation; Coronary artery disease; Coronary risk factors; Secondary prevention; Sibling pairs

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; CARDIOVASCULAR RISK; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HEART REHABILITATION; HOSPITAL CARE; HUMAN; HYPERTENSION; LIPID BLOOD LEVEL; PATIENT COMPLIANCE; RISK ASSESSMENT; SECONDARY PREVENTION; SIBLING; SMOKING CESSATION; SYSTOLIC BLOOD PRESSURE; TREATMENT OUTCOME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; CASE-CONTROL STUDIES; COMBINED MODALITY THERAPY; CORONARY ARTERY BYPASS; CORONARY DISEASE; FEMALE; FOLLOW-UP STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PATIENT ADMISSION; PRACTICE GUIDELINES; QUALITY ASSURANCE, HEALTH CARE; RECURRENCE; RISK FACTORS;

EID: 0034802208     PISSN: 03005860     EISSN: None     Source Type: Journal    
DOI: 10.1007/s003920170112     Document Type: Article

References (23)

1. Effects of intensive multiple risk factor reduction on coronary atherosclerosis and clinical cardiac events in men and women with coronary artery disease
2. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease (1994) the Scandinavian Simvastatin Survival Study (4S)
3. Preventing heart attack and death in patients with coronary disease
4. Joint British recommendations on prevention of coronary heart disease in clinical practice: Summary
5. Prevention of coronary heart disease in clinical practice: Recommendations of the Task Force of the European Society of Cardiology European Atherosclerosis Society and European Society of Hypertension
6. A European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. EUROASPIRE Study Group. European action on secondary prevention through intervention to reduce events
7. The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)
8. Ann Intern Med
9. Prevention of coronary heart disease in clinical practice: Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention
10. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
11. Risk-reduction therapy: The challenge to change: Presented at the 68th Scientific Sessions of the American Heart Association November 13, 1995 Anaheim, California
12. Long-term effects of inhospital cardiac rehabilitation on the cardiac risk profile: A case control study in pairs of sibling with myocardial infarction
13. Hypertension among siblings of persons with premature coronary heart disease
14. Blood-pressure control in the hypertensive population
15. Secondary prevention in coronary heart disease: Baseline survey of provision in general practice
16. Do the results of randomized clinical trials of cardiovascular drugs influence medical practice?
17. The multilevel compliance challenge: Recommendations for a call to action. A statement for healthcare professionals
18. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels
19. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on death from cardiovascular causes, myocardial infarction, and stroke in high-risk patients
20. Empfehlungen zur umfassenden risikoverringerung für patienten mit koronarer herzerkrankung
21. Leitlinie: Koronare herzkrankheit/angina pectoris
22. Assessment of cardiovascular risk by use of multiple-risk-factor assessment equations. A statement for healthcare professionals from the American Heart Association and the American College of Cardiology
23. Inappropriate implementation of guideline-recommended use of ACE inhibitors after acute myocardial infarction in patients with left ventricular dysfuntion